A suicide gene approach using the human pro-apoptotic protein tBid inhibits HIV-1 replication |
| |
Authors: | Peter M Huelsmann Andreas D Hofmann Stefanie A Knoepfel Jasmin Popp Pia Rauch Francesca Di Giallonardo Christina Danke Eva Gueckel Axel Schambach Horst Wolff Karin J Metzner Christian Berens |
| |
Affiliation: | 1.University of Erlangen-Nuremberg, Institute of Clinical and Molecular Virology,Erlangen,Germany;2.University of Erlangen-Nuremberg, Department Biology,Erlangen,Germany;3.University of Zurich, University Hospital Zurich, Department of Medicine, Division of Infectious Diseases and Hospital Epidemiology,Zurich,Switzerland;4.University of Erlangen-Nuremberg, Department of Internal Medicine III,Erlangen,Germany;5.Hannover Medical School, Department of Experimental Hematology,Hannover,Germany;6.Helmholtz Zentrum München, Institute of Virology,Neuherberg,Germany |
| |
Abstract: | BackgroundRegulated expression of suicide genes is a powerful tool to eliminate specific subsets of cells and will find widespread usage in both basic and applied science. A promising example is the specific elimination of human immunodeficiency virus type 1 (HIV-1) infected cells by LTR-driven suicide genes. The success of this approach, however, depends on a fast and effective suicide gene, which is expressed exclusively in HIV-1 infected cells. These preconditions have not yet been completely fulfilled and, thus, success of suicide approaches has been limited so far. We tested truncated Bid (tBid), a human pro-apoptotic protein that induces apoptosis very rapidly and efficiently, as suicide gene for gene therapy against HIV-1 infection.ResultsWhen tBid was introduced into the HIV-1 LTR-based, Tat- and Rev-dependent transgene expression vector pLRed(INS)2R, very efficient induction of apoptosis was observed within 24 hours, but only in the presence of both HIV-1 regulatory proteins Tat and Rev. Induction of apoptosis was not observed in their absence. Cells containing this vector rapidly died when transfected with plasmids containing full-length viral genomic DNA, completely eliminating the chance for HIV-1 replication. Viral replication was also strongly reduced when cells were infected with HIV-1 particles.ConclusionsThis suicide vector has the potential to establish a safe and effective gene therapy approach to exclusively eliminate HIV-1 infected cells before infectious virus particles are released. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|